Catalent, Inc. Profile Avatar - Palmy Investing

Catalent, Inc.

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Techno…
Drug Manufacturers - Specialty & Generic
US, Somerset [HQ]
CTLT/Financial Reporting

Income Statements

14 Sheets · Starting from None
In Million USD. Margins, Growth Rates In %
Metric 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 None
Revenue
1,531.00 1,694.00 1,800.00 1,827.00 1,830.00 1,848.00 2,075.00 2,463.00 2,518.00 3,094.00 3,998.00 4,828.00 4,276.00 - -
EPS
-0.46 -0.21 -0.40 0.14 1.77 0.89 0.88 0.64 0.92 1.15 3.15 2.74 -1.28 - -
Profit
502.00 558.00 568.00 598.00 615.00 587.00 654.00 752.00 805.00 983.00 1,352.00 1,640.00 1,060.00 - -
Pre Tax
-5.00 18.00 -23.00 67.00 112.00 144.00 135.00 152.00 160.00 260.00 715.00 605.00 -315.00 - -
ETR
-438.89 2.69 -100.84 73.44 -86.84 23.26 19.03 45.00 14.29 15.25 18.18 14.21 26.35 - -
Net
-54.00 -24.00 -46.00 16.00 212.00 111.00 109.00 83.00 137.00 173.00 585.00 499.00 -232.00 - -
EBITDA
291.00 352.00 355.00 253.00 235.00 245.00 243.00 282.00 290.00 397.00 643.00 727.00 79.00 - -
Operating Income
186.00 198.00 204.00 240.00 259.00 217.00 234.00 271.00 61.00 143.00 354.00 349.00 -137.00 - -
Interest Income
- - - - - - - - - - - - - - - - 111.00 126.00 110.00 123.00 184.00 - -
Loss
-1,329.00 -1,475.00 -1,572.00 -1,563.00 -1,552.00 -1,618.00 -1,823.00 -2,173.00 -2,224.00 -2,688.00 -3,352.00 -4,073.00 -4,203.00 - -
Cost of Revenue
-1,029.00 -1,136.00 -1,231.00 -1,229.00 -1,215.00 -1,260.00 -1,420.00 -1,710.00 -1,712.00 -2,111.00 -2,646.00 -3,188.00 -3,216.00 - -
Operating Expenses
-299.00 -339.00 -340.00 -334.00 -337.00 -358.00 -402.00 -462.00 -512.00 -577.00 -706.00 -885.00 -987.00 - -
Depreciation and Amortization
-115.00 -129.00 -152.00 -142.00 -140.00 -140.00 -146.00 -190.00 -228.00 -253.00 -289.00 -378.00 -422.00 - -
Interest Expenses
-165.00 -183.00 -203.00 -163.00 -105.00 -88.00 -90.00 -111.00 -110.00 -126.00 -110.00 -123.00 -184.00 - -
Other Expenses
-42.00 -17.00 -48.00 -33.00 -60.00 -3.00 -26.00 -26.00 -98.00 -116.00 -361.00 -256.00 -204.00 - -
WA Shares Outstanding
117.00 117.00 117.00 117.00 119.00 124.00 125.00 131.00 144.00 149.00 168.00 176.00 181.00 - -
End of CTLT's Analysis
CIK: 1596783 CUSIP: 148806102 ISIN: US1488061029 LEI: - UEI: -
Secondary Listings
CTLT has no secondary listings inside our databases.